ciprofloxacin has been researched along with penicillin g in 133 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (6.02) | 18.7374 |
1990's | 19 (14.29) | 18.2507 |
2000's | 46 (34.59) | 29.6817 |
2010's | 50 (37.59) | 24.3611 |
2020's | 10 (7.52) | 2.80 |
Authors | Studies |
---|---|
Maiese, WM; Singh, MP; Timmermann, BN; Wächter, G; Woldemichael, GM | 1 |
Inagaki, H; Kawakami, K; Kawato, HC; Matsuhashi, N; Miyauchi, RN; Miyauchi, S; Ohki, H; Takahashi, H; Takemura, M | 1 |
Miller, MJ; Möllmann, U; Nora, GP | 1 |
Duewelhenke, N; Eysel, P; Krut, O | 1 |
Heldreth, B; Jang, S; Long, TE; Revell, KD; Turos, E | 1 |
Kwon, DH; Lu, CD | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Appelbaum, PC; Bogdanovich, T; Clark, C; Dewasse, B; Ednie, L; McGhee, P; Smith, K | 1 |
Campbell, BJ; Edwards, SW; Hart, CA; Martin, HM; Rhodes, JM; Roberts, CL; Subramanian, S | 1 |
Bonnet, R; Caniça, M; Ferreira, E; Manageiro, V; Mendonça, N; Robin, F; Salgado, MJ | 1 |
Appelbaum, PC; Ednie, LM; Hawser, S; Lociuro, S; Smith, K | 1 |
Al-Khafaji, NC; Borovskaya, AD; Govorun, VM; Ilina, EN; Kubanova, AA; Malakhova, MV; Sidorenko, SV; Vereshchagin, VA | 1 |
Beckius, ML; Fraser, SL; Galloway, RL; Griffith, ME; Hospenthal, DR; Mende, K; Miller, RS; Murray, CK; Pimentel, G; Ressner, RA | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Benton, BM; Debabov, DV; Difuntorum, S; Krause, KM; Renelli, M; Wu, TX | 1 |
Amsler, KM; Bush, K; Davies, TA; Jacobs, MR; Shang, W | 1 |
Arhin, FF; Bassett, A; Bassett, J; Heine, HS; Ivins, BE; Lehoux, D; Miller, L; Moeck, G; Parr, TR | 1 |
Albertí, S; Beceiro, A; Bou, G; Garau, M; Gutiérrez, O; Juan, C; Oliver, A; Pérez, JL | 1 |
Bell, JM; Biedenbach, DJ; Jones, RN; Sader, HS; Turnidge, JD | 1 |
Karlowsky, JA; Zhanel, GG | 1 |
Caugant, DA; Fredlund, H; Hedberg, ST; Nicolas, P; Olcén, P; Unemo, M | 1 |
Abood, N; Boykin, DW; Hu, L; Kully, ML | 3 |
Fritsche, TR; Jones, RN; Sader, HS | 1 |
Appelbaum, PC; Ednie, LM; Kosowska-Shick, K; McGhee, P | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Hafkin, B; Hoban, DJ; Kaplan, N; Karlowsky, JA; Zhanel, GG | 1 |
Brunner, LS; Haas, W; Lee, JC; Morris, TW; Pillar, CM; Zurenko, GE | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Arhin, FF; Draghi, DC; Moeck, G; Parr, TR; Pillar, CM; Sahm, DF | 1 |
Cho, HS; Giske, CG; Lee, K; Sundman, K; Toleman, MA; Walsh, TR; Yong, D | 1 |
Bonnet, R; Casin, I; Doublet, B; Fabre, L; Le Fleche, A; Robin, F; Weill, FX | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Ambrose, PG; Bassett, J; Beaudry, A; Bhavnani, SM; Critchley, I; Gill, SC; Heine, HS; Janjic, N; Li, J; Miller, L; Rubino, CM; Stone, KC | 1 |
Amsler, KM; Bush, K; Foleno, BD; He, W; Lynch, AS; Macielag, MJ; Morrow, BJ | 1 |
Blango, MG; Mulvey, MA | 1 |
Ardanuy, C; Brito-Avô, A; Gonçalo-Marques, J; Liñares, J; Morais, A; Pires, R; Rolo, D; Santos-Sanches, I | 1 |
Dal-Ré, R; García-de-Lomas, J; García-Delafuente, C; Iriarte, V; Martín-Herrero, JE; Mazón, A; Pérez-Trallero, E; Robles, P | 1 |
Duan, Y; Hu, W; Li, M; Qian, Y; Shi, W; Yang, L | 1 |
Goswami, M; Jawali, N | 1 |
Barrow, EW; Barrow, WW; Berlin, KD; Bourne, CR; Bourne, PC; Bunce, RA | 1 |
Biedenbach, DJ; Castanheira, M; Jones, RN | 1 |
Biedenbach, DJ; Hammerschlag, MR; Jones, RN; Kohlhoff, SA; Roblin, PM | 1 |
Huang, CT; Li, LH; Li, SY; Liao, MH; Lin, KY; Wong, WW; Yen, MY | 1 |
Ashby, CR; Hardej, D; Khadtare, NS; Kulkarni, SS; Singh, S; Talele, TT | 1 |
Allen, VG; Farrell, DJ; Lo, S; Low, DE; Melano, RG; Perusini, SJ; Rebbapragada, A; Tan, J; Tijet, N; Towns, L | 1 |
Aubart, K; Duan, Y; Fang, Y; Hu, W; Ma, H; Shi, W; Yang, L; Zonis, R | 1 |
Chiba, T; Hasegawa, T; Horita, Y; Kremer, L; Kuroishi, R; Lee, Y; Ogawa, K; Onozaki, K; Sato, Y; Takii, T | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
An, LK; Chen, JW; Gu, LQ; Huang, ZS; Wang, LX; Wu, XW; Wu, ZP; Zhang, HB; Zhang, W | 1 |
Anderson, KC; Kellogg, GE; Sarkar, A | 1 |
Anderson, B; Dickey, S; Gergeres, D; Lim, DV; Ramaraju, P; Thomas, J; Turos, E | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Inagaki, H; Kitamura, T; Komoriya, S; Kuroyanagi, J; Miyauchi, RN; Nagamochi, M; Odagiri, T; Sugimoto, Y; Takahashi, H | 1 |
Ashby, CR; Hardej, D; Patel, BA; Talele, TT | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Doležal, M; Kubíček, V; Kučera, R; Kuneš, J; Mandíková, J; Paterová, P; Servusová, B; Zitko, J | 1 |
Genta-Jouve, G; Greff, S; Massi, L; Perez, T; Thomas, OP; Zubia, M | 1 |
Basireddy, VS; Dharmarajan, S; Guttala, RS; Jagarlamudi, PS; Mukkara, LD; Pagadala, LR; Perumal, Y; Ravirala, N; Singh, A; Singireddi, S; Thummaluru, VR; Ummanni, R; Upadhyayula, SM | 1 |
Hu, W; Lv, F; Shi, W; Xing, D; Yang, L; Yang, S; Yang, Y; Zhao, Z | 1 |
Bao, Y; Huang, X; Lan, S; Wang, T; Zhang, X; Zhu, S | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Benfodda, Z; Bénimèlis, D; Boibessot, T; Dunyach-Rémy, C; Lavigne, JP; Lebeau, A; Meffre, P; Szurmant, H; Zschiedrich, CP | 1 |
Chandrasekaran, B; Cherukupalli, S; Hampannavar, GA; Karpoormath, R; Palakollu, VN; Thapliyal, N | 1 |
Ashenden, S; Bender, A; Cokol, M; Karakoc, I; Kuru, N; Mason, DJ; Meral, S; Stott, I; Weinstein, ZB | 1 |
Castro, HC; Costa, DCS; da Silva, FC; Ferreira, VF; Figueiredo, AMS; Lopes, SMM; Novais, JS; Pinho E Melo, TMVD | 1 |
Sandargo, B; Stadler, M; Surup, F; Thongbai, B | 1 |
Guo, H | 1 |
Cai, S; Fang, Z; Guo, Q; Huang, X; Li, Y; Lin, H; Lu, YJ; Sun, N; Tang, Z; Wong, KY; Wong, WL; Yuan, W | 1 |
Gao, F; Huang, G; Xiao, J | 1 |
Bangalore, PK; Bollikanda, RK; Choudante, PC; Kantevari, S; Misra, S; Sridhar, B; Sriram, D; Vagolu, SK; Veeragoni, DK | 1 |
Klein, CD; van Oosten, LN | 1 |
Amada, H; Endo, M; Hitaka, K; Kamitani, M; Masuko, A; Mihara, Y; Mima, M; Ohtake, N; Sugiyama, H; Takata, I; Takeuchi, T; Tamura, Y; Tanaka-Yamamoto, N; Ushiyama, F; Wada, R | 1 |
Ba, Z; Chang, L; Gou, S; Li, B; Liu, H; Ni, J; Ouyang, X; Zhang, J; Zhang, T; Zhang, Y; Zhong, C; Zhu, N; Zhu, Y | 1 |
Bhando, T; Brown, ED; Carfrae, L; Ellis, MJ; Johnson, JW; MacNair, C; Magolan, J; Piquette, ZA; Ritchie, NE; Saliba, P | 1 |
Benada, O; Bogdanová, K; Dávidová, E; Do Pham, DD; Fišer, R; Galandáková, A; Helusová, M; Kolář, M; Krásný, L; Křížek, T; Mikušová, G; Mojr, V; Pohl, R; Pospíšil, J; Rejman, D; Šanderová, H; Sedláková, MH; Sudzinová, P; Večeřová, R; Vítovská, D | 1 |
Angeles-Solano, M; Brock, JW; Grosser, MR; Murphy, KE; Pugh, BA; Rao, AB; Wolfe, AL | 1 |
Chulay, JD; Friedlander, AM; Kelly, DJ; Mikesell, P | 1 |
Fasching, CE; Gerding, DN; Moody, JA; Peterson, LR; Sinn, LM | 1 |
Jenkins, GC; Kelsey, SM; Newland, AC; Shaw, E; Wood, ME | 1 |
Korting, HC; Lukacs, A | 1 |
Benes, S; Cummings, M; Draft, K; McCormack, WM; Smith, BL | 1 |
Kelsey, SM; Newland, AC; Shaw, E; Wood, ME | 1 |
Hoogeterp, JJ; Krul, AM; Mattie, H; Terporten, P; van Furth, R | 1 |
Traub, WH | 1 |
Fasching, CE; Gerding, DN; Moody, JA; Peterson, LR | 1 |
Armynot du Chatelet, AM; Attisso, MA; Maillols, M; Simeon de Buochberg, M; Zuccarelli, M | 1 |
Newland, AC; Wood, ME | 1 |
Nielsen, PE; Thelle, T; Tvede, M | 1 |
Appelbaum, PC; Jacobs, MR; Pankuch, GA | 1 |
Chmel, H; Evers, ML; Win, A | 1 |
Asikainen, S; Forsblom, B; Jousimies-Somer, H; Pajukanta, R; Piekkola, M | 1 |
Bowyer, GW; Cumberland, N | 1 |
Feik, D; Rams, TE; Slots, J | 1 |
Alaluusua, S; Asikainen, S; Jousimies-Somer, H; Pajukanta, R; Saarela, M | 1 |
Flynn, MJ; Slots, J | 1 |
de Jong, M; de Jong, P; Kuijper, E; van der Lelie, J | 1 |
Cooper, BW; Lawlor, MT; Nightingale, CH; Quintiliani, R; Sullivan, MC | 1 |
Gökturk, E; Günal, I; Kiraz, N; Oztuna, V; Seber, S; Türkay, S | 1 |
Andrews, JM; Brenwald, NP; Hadley, N; Wise, R | 1 |
Abele-Horn, M; Heesemann, J; Held, E; Küchle, C; Menninger, M | 1 |
Cavallo, JD; Fabre, R; Martet, G; Nicolas, P | 1 |
Bergh, K; Løseth, K; Persen, L; Witsø, E | 1 |
Chiba, A; Harada, S; Hasegawa, M; Kaneko, A; Kobayashi, I; Koyama, H; Matsuzaki, K; Omika, K; Sasaki, J; Sato, Y | 1 |
Hashido, H; Ishigo, S; Iwata, I; Matsubara, S; Matsukawa, Y; Mikamo, H; Sawamura, H; Suematsu, H; Tamaya, T | 1 |
Bäckman, C; Lindfors, E; Myllyniemi, AL; Niemi, A; Rannikko, R | 1 |
Domínguez, L; Fernández-Garayzábal, JF; Latre, MV; Moreno, MA; Rodríguez, AA; Vela, AI | 1 |
Henneberg, JP; Neubert, U | 1 |
Fukuda, H; Kawamura, Y | 1 |
Chimishkian, KL; Dmitrieva, NV; Larionova, VB; Minenko, SV; Ptushkin, VV; Sokolova, EN; Zhukov, NV | 1 |
Bossi, P; Bricaire, F | 1 |
Doganay, M; Esel, D; Sumerkan, B | 1 |
Cao, WL; Wu, XZ; Yang, LG; Zheng, HP | 1 |
Iwashima, A; Kiguchi, T; Sato, K; Yamaguchi, M | 1 |
Ayaslioglu, E; Beygo, B; Erkek, E; Ozluk, U | 1 |
Arechavala, AI; Bianchi, MH; Maiolo, E; Negroni, R; Olivares, L; Santiso, G | 1 |
Liu, ZQ; Yang, PC; Zheng, PY | 1 |
Avril, MF; Dupin, N; Farhi, D; Gerhardt, P; Hotz, C; Morand, P; Poupet, H; Poyart, C; Sednaoui, P | 1 |
Battikh, R; Ben Abdelhafidh, N; Bougrine, F; Bouziani, A; M'Sadek, F; Madhi, W; Othmani, S; Yedeas, M | 1 |
Dorin, M; Kawahata, T; Morita-Ishihara, T; Nakayama, S; Ohnishi, M; Shimuta, K; Unemo, M | 1 |
Al-Ahmad, A; Ameen, H; Anderson, AC; Hellwig, E; Karygianni, L; Pelz, K; Spitzmüller, B; Wittmer, A | 1 |
Atli, SB; Parlak, E; Parlak, M | 1 |
Althaus, CL; Foerster, S; Hathaway, LJ; Low, N; Unemo, M | 1 |
Cole, K; Cole, MJ; Crook, DW; De Silva, D; Demczuk, W; Eyre, DW; Grad, YH; Martin, I; Mulvey, MR; Paul, J; Peters, J; Peto, TEA; Walker, AS | 1 |
Harrer, T; Schliep, S; Schuler, G; Simon, M; Tajmir-Riahi, A; Wörl, P | 1 |
de Moraes, C; Dias, UJ; Gorla, MC; Lemos, AP; Pinhata, JMW | 1 |
Cole, MJ; Foerster, S; Jacobsson, S; Jönsson, A; Unemo, M | 1 |
Blaskovich, MAT; Cooper, MA; Gong, Y; Kavanagh, A; Ramu, S | 1 |
Hamill, MM; Kajumbula, H; Kakooza, F; Kyambadde, P; Lamorde, M; Manabe, YC; Mande, E; Mbabazi, O; Mugasha, R; Musinguzi, P; Wagner, J; Walwema, R; Workneh, M; Zenilman, J | 1 |
Bjarnsholt, T; Christophersen, L; Eldrup, N; Moser, C; Qvortrup, K; Schwartz, F; Sunnerhagen, T; Vogt, K | 1 |
Bamford, C; Gigi, R; Jung, H; Martinez, FP; Mdingi, MM; Mitchev, N; Peters, RPH; Shroufi, A | 1 |
6 review(s) available for ciprofloxacin and penicillin g
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
An insight on synthetic and medicinal aspects of pyrazolo[1,5-a]pyrimidine scaffold.
Topics: Animals; Chemistry Techniques, Synthetic; Humans; Pyrazoles; Pyrimidines | 2017 |
Isatin derivatives and their anti-bacterial activities.
Topics: Anti-Bacterial Agents; Bacteria; Humans; Isatin; Structure-Activity Relationship | 2019 |
Current scenario of tetrazole hybrids for antibacterial activity.
Topics: Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Tetrazoles | 2019 |
[Mycoplasma hominis. A rare causative agent of acute pyelonephritis].
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Doxycycline; Drug Therapy, Combination; Female; Humans; Mycoplasma hominis; Mycoplasma Infections; Penicillin G; Penicillins; Pyelonephritis | 1997 |
[Anthrax in the era of biowarfare].
Topics: Adult; Amoxicillin; Anthrax; Anti-Bacterial Agents; Anti-Infective Agents; Biological Warfare; Bioterrorism; Child; Ciprofloxacin; Doxycycline; Female; Humans; Infant, Newborn; Male; Ofloxacin; Penicillin G; Penicillins; Pregnancy; Prognosis; Risk Factors; Time Factors | 2003 |
6 trial(s) available for ciprofloxacin and penicillin g
Article | Year |
---|---|
In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections.
Topics: Anti-Bacterial Agents; Cephalosporins; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Skin Diseases, Bacterial; Staphylococcus | 2008 |
A comparative study of intravenous ciprofloxacin and benzylpenicillin versus netilmicin and piperacillin for the empirical treatment of fever in neutropenic patients.
Topics: Adult; Bacterial Infections; Ciprofloxacin; Drug Therapy, Combination; Fever; Humans; Injections, Intravenous; Middle Aged; Netilmicin; Neutropenia; Penicillin G; Piperacillin; Prospective Studies; Randomized Controlled Trials as Topic | 1990 |
Evaluation of difloxacin in the treatment of uncomplicated urethral gonorrhea in men.
Topics: Adult; Anti-Bacterial Agents; Chlamydia Infections; Ciprofloxacin; Clinical Trials as Topic; Fluoroquinolones; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillin G; Tetracycline | 1989 |
Intravenous ciprofloxacin as empirical treatment of febrile neutropenic patients.
Topics: Adult; Agranulocytosis; Bacteria; Bacterial Infections; Ciprofloxacin; Drug Therapy, Combination; Fever; Humans; Infusions, Intravenous; Middle Aged; Netilmicin; Neutropenia; Penicillin G; Piperacillin; Random Allocation | 1989 |
Intravenous ciprofloxacin in the treatment of infection in immunocompromised patients.
Topics: Adolescent; Adult; Bacterial Infections; Ciprofloxacin; Drug Therapy, Combination; Humans; Immune Tolerance; Infusions, Intravenous; Middle Aged; Netilmicin; Opportunistic Infections; Penicillin G; Piperacillin; Random Allocation | 1986 |
[Benzylpenicillin efficacy for neutropenic infection prophylaxis in patients with cancer and postcytostatic neutropenia].
Topics: Adolescent; Adult; Anti-Infective Agents; Antibiotic Prophylaxis; Antineoplastic Agents; Bacterial Infections; Ciprofloxacin; Enterococcus faecalis; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Neoplasms; Neutropenia; Penicillin G | 2002 |
121 other study(ies) available for ciprofloxacin and penicillin g
Article | Year |
---|---|
Antibacterial diterpenes from Calceolaria pinifolia.
Topics: Animals; Anti-Bacterial Agents; Argentina; Bacillus subtilis; Diterpenes; Erythrocytes; Escherichia coli; Female; Humans; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Molecular Conformation; Molecular Structure; Plants, Medicinal; Scrophulariaceae; Staphylococcus aureus | 2003 |
Synthesis and structure-activity relationships of 5-amino-6-fluoro-1-[(1R,2S)-2-fluorocyclopropan-1-yl]-8-methylquinolonecarboxylic acid antibacterials having fluorinated 7-[(3R)-3-(1-aminocyclopropan-1-yl)pyrrolidin-1-yl] substituents.
Topics: Anti-Bacterial Agents; Cyclopropanes; Drug Resistance, Bacterial; Gram-Positive Bacteria; Microbial Sensitivity Tests; Quinolones; Stereoisomerism; Structure-Activity Relationship | 2003 |
The synthesis and in vitro testing of structurally novel antibiotics derived from acylnitroso Diels-Alder adducts.
Topics: Anti-Bacterial Agents; Escherichia coli; Microbial Sensitivity Tests; Molecular Structure | 2006 |
Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Antimycin A; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; Chloramphenicol; Clindamycin; Dose-Response Relationship, Drug; Fluoroquinolones; Glycolysis; HeLa Cells; Humans; Lactic Acid; Linezolid; Macrolides; Mitochondria; Osteoblasts; Oxazolidinones; Rotenone; Tetracyclines; Time Factors | 2007 |
N-thiolated beta-lactams: Studies on the mode of action and identification of a primary cellular target in Staphylococcus aureus.
Topics: Anti-Bacterial Agents; beta-Lactams; Coenzyme A; Disulfides; Microbial Sensitivity Tests; Oxidation-Reduction; Staphylococcus aureus; Structure-Activity Relationship; Sulfhydryl Compounds; Thiosulfonic Acids | 2007 |
Polyamine effects on antibiotic susceptibility in bacteria.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Drug Resistance, Bacterial; Drug Synergism; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Polyamines; Spermine; Staphylococcus aureus | 2007 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
In vitro activity of DC-159a, a new broad-spectrum fluoroquinolone, compared with that of other agents against drug-susceptible and -resistant pneumococci.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Culture Media; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Mutation; Streptococcus pneumoniae | 2008 |
Replication of Colonic Crohn's Disease Mucosal Escherichia coli Isolates within Macrophages and Their Susceptibility to Antibiotics.
Topics: Animals; Anti-Bacterial Agents; Cell Line; Cells, Cultured; Colon; Crohn Disease; Culture Media; Escherichia coli; Humans; Macrophages; Mice; Microbial Sensitivity Tests; Monocytes; Mucous Membrane | 2008 |
The Lys234Arg substitution in the enzyme SHV-72 is a determinant for resistance to clavulanic acid inhibition.
Topics: Amino Acid Substitution; Amoxicillin; Anti-Bacterial Agents; Arginine; Aztreonam; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Clavulanic Acid; Computer Simulation; Imipenem; Isoelectric Focusing; Kinetics; Klebsiella pneumoniae; Lysine; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Penicillins; Protein Conformation; Protein Structure, Tertiary | 2008 |
Antistreptococcal activity of AR-709 compared to that of other agents.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Pyrimidines; Streptococcus pneumoniae; Streptococcus pyogenes; Tetrahydrofolate Dehydrogenase; Trimethoprim, Sulfamethoxazole Drug Combination | 2008 |
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Drug Resistance, Bacterial; Fluoroquinolones; Genetic Markers; Genotype; Gonorrhea; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Neisseria gonorrhoeae; Penicillins; Sequence Analysis, DNA; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tetracycline | 2008 |
Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira.
Topics: Ampicillin; Anti-Bacterial Agents; Azithromycin; Cefepime; Cefotaxime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Egypt; Hawaii; Humans; Leptospira; Leptospirosis; Levofloxacin; Microbial Sensitivity Tests; Nicaragua; Ofloxacin; Tetracycline; Thailand | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
In vitro activity of telavancin against resistant gram-positive bacteria.
Topics: Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; In Vitro Techniques; Lipoglycopeptides; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus; Streptococcus | 2008 |
Efficacy of oritavancin in a murine model of Bacillus anthracis spore inhalation anthrax.
Topics: Administration, Inhalation; Animals; Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Disease Models, Animal; Glycopeptides; Humans; Lipoglycopeptides; Mice; Microbial Sensitivity Tests; Spores, Bacterial; Treatment Outcome | 2008 |
Characterization of the new metallo-beta-lactamase VIM-13 and its integron-borne gene from a Pseudomonas aeruginosa clinical isolate in Spain.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Cloning, Molecular; DNA Primers; DNA, Bacterial; Genes, Bacterial; Genetic Variation; Humans; Imipenem; Integrons; Kinetics; Meropenem; Molecular Sequence Data; Phylogeny; Pseudomonas aeruginosa; Pseudomonas Infections; Recombinant Proteins; Sequence Homology, Amino Acid; Spain; Thienamycins | 2008 |
Activities of dalbavancin against a worldwide collection of 81,673 gram-positive bacterial isolates.
Topics: Anti-Bacterial Agents; Asia; Drug Resistance, Bacterial; Europe; Gram-Positive Bacteria; Humans; Latin America; Microbial Sensitivity Tests; North America; Pacific Ocean; Quality Control; Teicoplanin; Vancomycin | 2009 |
In vitro activity of Iclaprim against respiratory and bacteremic isolates of Streptococcus pneumoniae.
Topics: Bacteremia; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Pyrimidines; Respiratory System; Streptococcus pneumoniae; Trimethoprim, Sulfamethoxazole Drug Combination | 2009 |
Antibiotic susceptibility and characteristics of Neisseria meningitidis isolates from the African meningitis belt, 2000 to 2006: phenotypic and genotypic perspectives.
Topics: Africa; Genotype; Humans; Meningitis, Meningococcal; Microbial Sensitivity Tests; Neisseria meningitidis; Phenotype; Sequence Analysis, DNA; Time Factors | 2009 |
Synthesis and in vitro activity of dicationic bis-benzimidazoles as a new class of anti-MRSA and anti-VRE agents.
Topics: Anti-Bacterial Agents; Benzimidazoles; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Structure-Activity Relationship; Vancomycin Resistance | 2009 |
Potency and bactericidal activity of iclaprim against recent clinical gram-positive isolates.
Topics: Anti-Bacterial Agents; Enterococcus faecalis; Europe; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Hospitalization; Humans; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pyrimidines; Staphylococcus aureus; Streptococcus; United States | 2009 |
Comparative antipneumococcal activities of sulopenem and other drugs.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Lactams; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Streptococcus pneumoniae | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Optimization of the central linker of dicationic bis-benzimidazole anti-MRSA and anti-VRE agents.
Topics: Anti-Bacterial Agents; Benzimidazoles; Cations; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pentamidine; Structure-Activity Relationship; Vancomycin Resistance | 2009 |
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
Topics: Anti-Bacterial Agents; Benzofurans; Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); Enterobacteriaceae; Enterococcus; Microbial Sensitivity Tests; Moraxella catarrhalis; Pyrones; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus pneumoniae | 2009 |
Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria.
Topics: Anti-Bacterial Agents; Azepines; Bacteria, Anaerobic; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Synthesis and structure-activity relationship of dicationic diaryl ethers as novel potent anti-MRSA and anti-VRE agents.
Topics: Anti-Bacterial Agents; Benzimidazoles; Enterococcus; Ethers; Indoles; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pentamidine; Phenyl Ethers; Structure-Activity Relationship; Vancomycin Resistance | 2009 |
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus faecium; Glycopeptides; Gram-Positive Bacteria; Humans; Lipoglycopeptides; Microbial Sensitivity Tests; Staphylococcus aureus; Streptococcus | 2009 |
Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Carboxylic Ester Hydrolases; Cefotaxime; Cefuroxime; Cephalosporins; Cephalothin; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; India; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillins; Sequence Analysis, DNA; Sequence Homology, Amino Acid | 2009 |
Molecular and biochemical characterization of the natural chromosome-encoded class A beta-lactamase from Pseudomonas luteola.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Catheters, Indwelling; Chromosomes, Bacterial; Cloning, Molecular; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Genetic Variation; Isoelectric Focusing; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Plasmids; Pseudomonas; Pseudomonas Infections; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Substrate Specificity | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.
Topics: Animals; Anthrax; Anti-Bacterial Agents; Bacillus anthracis; beta-Lactamases; beta-Lactams; Blood Proteins; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Inhalation Exposure; Mice; Mice, Inbred BALB C; Models, Biological | 2010 |
In vitro antibacterial activities of JNJ-Q2, a new broad-spectrum fluoroquinolone.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Design; Drug Resistance, Bacterial; Escherichia coli; Fluoroquinolones; Methicillin-Resistant Staphylococcus aureus; Streptococcus pneumoniae | 2010 |
Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Cell Membrane Permeability; Cells, Cultured; Drug Resistance, Bacterial; Endosomes; Escherichia coli; Escherichia coli Infections; Female; Humans; Mice; Mice, Inbred CBA; Microbial Sensitivity Tests; Recurrence; Urinary Bladder; Urinary Tract Infections; Urothelium | 2010 |
Emergence of ciprofloxacin-nonsusceptible Streptococcus pyogenes isolates from healthy children and pediatric patients in Portugal.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Outer Membrane Proteins; Bacterial Typing Techniques; Carrier Proteins; Child; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Molecular Epidemiology; Norfloxacin; Point Mutation; Portugal; Streptococcal Infections; Streptococcus pyogenes | 2010 |
Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years (1996-1997 to 2006-2007).
Topics: Ampicillin; Anti-Bacterial Agents; Cefotaxime; Erythromycin; Haemophilus influenzae; Lincosamides; Macrolides; Microbial Sensitivity Tests; Penicillins; Respiratory Tract Infections; Spain; Streptococcus pneumoniae; Streptococcus pyogenes; Streptogramin B | 2010 |
Design, synthesis, and antibacterial activity of 2,5-dihydropyrrole formyl hydroxyamino derivatives as novel peptide deformylase inhibitors.
Topics: Amidohydrolases; Amines; Anti-Bacterial Agents; Drug Design; Pyrroles; Structure-Activity Relationship | 2010 |
N-acetylcysteine-mediated modulation of bacterial antibiotic susceptibility.
Topics: Acetylcysteine; Anti-Bacterial Agents; Culture Media; Drug Resistance, Bacterial; Expectorants; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests | 2010 |
Inhibition of antibiotic-resistant Staphylococcus aureus by the broad-spectrum dihydrofolate reductase inhibitor RAB1.
Topics: Anti-Bacterial Agents; Enzyme Inhibitors; Inhibitory Concentration 50; Microbial Sensitivity Tests; Protein Structure, Secondary; Protein Structure, Tertiary; Staphylococcus aureus; Tetrahydrofolate Dehydrogenase | 2010 |
Determination of CEM-101 activity tested against clinical isolates of Neisseria meningitidis from a worldwide collection.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Minocycline; Neisseria meningitidis; Penicillins; Rifampin; Sulfamethoxazole; Triazoles; Trimethoprim | 2010 |
Update on fusidic acid (CEM-102) tested against Neisseria gonorrhoeae and Chlamydia trachomatis.
Topics: Anti-Bacterial Agents; Chlamydia trachomatis; Fusidic Acid; Neisseria gonorrhoeae | 2010 |
Characteristics and dissemination of mosaic penicillin-binding protein 2-harboring multidrug-resistant Neisseria gonorrhoeae isolates with reduced cephalosporin susceptibility in northern Taiwan.
Topics: Anti-Bacterial Agents; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillin-Binding Proteins; Penicillins; Sexually Transmitted Diseases, Bacterial; Taiwan | 2010 |
The synthesis of phenylalanine-derived C5-substituted rhodanines and their activity against selected methicillin-resistant Staphylococcus aureus (MRSA) strains.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Phenylalanine; Rhodanine; Stereoisomerism; Structure-Activity Relationship | 2010 |
Molecular analysis of antimicrobial resistance mechanisms in Neisseria gonorrhoeae isolates from Ontario, Canada.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Cefixime; Ceftriaxone; Cephalosporins; DNA, Bacterial; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Neisseria gonorrhoeae; Ontario; Penicillin-Binding Proteins; Polymerase Chain Reaction; Sequence Analysis, DNA | 2011 |
Design, synthesis and antibacterial activity of 3-methylenepyrrolidine formyl hydroxyamino derivatives as novel peptide deformylase inhibitors.
Topics: Amidohydrolases; Anti-Bacterial Agents; Drug Design; Drug Resistance, Bacterial; Enzyme Inhibitors; Haemophilus influenzae; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pyrrolidines | 2011 |
Synthesis and evaluation of anti-tubercular activity of new dithiocarbamate sugar derivatives.
Topics: Antitubercular Agents; Carbohydrates; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxidoreductases; Thiocarbamates; Thioglucosides | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Synthesis, antimicrobial activity and possible mechanism of action of 9-bromo-substituted indolizinoquinoline-5,12-dione derivatives.
Topics: Anti-Bacterial Agents; Enzyme Inhibitors; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Models, Molecular; Quinolines; Spectrometry, Mass, Electrospray Ionization | 2011 |
Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Computational Biology; Drug Resistance, Bacterial; Hydrophobic and Hydrophilic Interactions; Ligands; Membrane Transport Proteins; Microbial Sensitivity Tests; Models, Molecular; Protein Binding; Protein Conformation; Quantitative Structure-Activity Relationship; Regression Analysis; Thermodynamics | 2012 |
Synthesis and antimicrobial activities of structurally novel S,S'-bis(heterosubstituted) disulfides.
Topics: Anti-Infective Agents; Candida albicans; Disulfides; Francisella tularensis; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Structure-Activity Relationship | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Design, synthesis, and biological evaluations of novel 7-[7-amino-7-methyl-5-azaspiro[2.4]heptan-5-yl]-8-methoxyquinolines with potent antibacterial activity against respiratory pathogens.
Topics: Animals; Anti-Bacterial Agents; Drug Design; Fluoroquinolones; Haemophilus influenzae; Male; Mice; Microbial Sensitivity Tests; Quinolones; Rats; Respiratory Tract Infections; Spiro Compounds; Staphylococcus aureus; Streptococcus pneumoniae | 2013 |
The synthesis and SAR study of phenylalanine-derived (Z)-5-arylmethylidene rhodanines as anti-methicillin-resistant Staphylococcus aureus (MRSA) compounds.
Topics: Anti-Bacterial Agents; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Phenylalanine; Rhodanine; Structure-Activity Relationship; Vancomycin | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Alkylamino derivatives of pyrazinamide: synthesis and antimycobacterial evaluation.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antitubercular Agents; Crystallography; Drug Evaluation, Preclinical; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide | 2014 |
Mahorones, highly brominated cyclopentenones from the red alga Asparagopsis taxiformis.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Antifungal Agents; Cyclopentanes; Humans; Hydrocarbons, Brominated; Indian Ocean; Molecular Structure; Rhodophyta | 2014 |
Design, synthesis and anti-mycobacterial activity of 1,2,3,5-tetrasubstituted pyrrolyl-N-acetic acid derivatives.
Topics: Acetates; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Design; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Pyrroles; Structure-Activity Relationship | 2014 |
Synthesis, antibacterial activity, and biological evaluation of formyl hydroxyamino derivatives as novel potent peptide deformylase inhibitors against drug-resistant bacteria.
Topics: Amidohydrolases; Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Enzyme Inhibitors; Microbial Sensitivity Tests; Molecular Structure; Oligopeptides; Structure-Activity Relationship | 2014 |
Synthesis and biological evaluation of levofloxacin core-based derivatives with potent antibacterial activity against resistant Gram-positive pathogens.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Levofloxacin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Penicillin Resistance; Streptococcus pneumoniae; Streptococcus pyogenes; Structure-Activity Relationship | 2015 |
The Rational Design, Synthesis, and Antimicrobial Properties of Thiophene Derivatives That Inhibit Bacterial Histidine Kinases.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Drug Design; Enzyme Inhibitors; Histidine Kinase; Humans; Microbial Sensitivity Tests; Models, Molecular; Signal Transduction; Thiophenes | 2016 |
Prediction of Antibiotic Interactions Using Descriptors Derived from Molecular Structure.
Topics: Anti-Bacterial Agents; Drug Interactions; Molecular Structure | 2017 |
Hetero-Diels-Alder reactions of novel 3-triazolyl-nitrosoalkenes as an approach to functionalized 1,2,3-triazoles with antibacterial profile.
Topics: Alkenes; Anti-Bacterial Agents; Biofilms; Cycloaddition Reaction; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Nitroso Compounds; Staphylococcus; Structure-Activity Relationship; Triazoles | 2018 |
Cysteine-Derived Pleurotin Congeners from the Nematode-Trapping Basidiomycete Hohenbuehelia grisea.
Topics: Acetylcysteine; Agaricales; Animals; Anti-Infective Agents; Basidiomycota; Cysteine; Fungi; Heterocyclic Compounds, 4 or More Rings; Magnetic Resonance Spectroscopy; Nematoda; Sulfhydryl Compounds; Sulfur; Thailand | 2018 |
Antibacterial activity of indolyl-quinolinium derivatives and study their mode of action.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Indoles; Microbial Sensitivity Tests; Molecular Structure; Quinolinium Compounds; Structure-Activity Relationship | 2019 |
Usnic Acid Enaminone-Coupled 1,2,3-Triazoles as Antibacterial and Antitubercular Agents.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Bacillus subtilis; Benzofurans; Lichens; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Triazoles | 2020 |
Machine Learning in Mass Spectrometry: A MALDI-TOF MS Approach to Phenotypic Antibacterial Screening.
Topics: Anti-Bacterial Agents; Escherichia coli; Machine Learning; Microbial Sensitivity Tests; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Staphylococcus aureus | 2020 |
Lead optimization of 8-(methylamino)-2-oxo-1,2-dihydroquinolines as bacterial type II topoisomerase inhibitors.
Topics: Anti-Bacterial Agents; Cell Survival; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Hep G2 Cells; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Quinolines; Streptococcus pneumoniae; Structure-Activity Relationship; Topoisomerase II Inhibitors; Transcriptional Regulator ERG; Vancomycin-Resistant Enterococci | 2020 |
Novel Broad-Spectrum Antimicrobial Peptide Derived from Anoplin and Its Activity on Bacterial Pneumonia in Mice.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Antineoplastic Agents; Cell Line; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Structure; Pneumonia, Bacterial; Pore Forming Cytotoxic Proteins; Structure-Activity Relationship; Wasp Venoms | 2021 |
Antibacterial Activity of Metergoline Analogues: Revisiting the Ergot Alkaloid Scaffold for Antibiotic Discovery.
Topics: | 2022 |
LEGO-Lipophosphonoxins: A Novel Approach in Designing Membrane Targeting Antimicrobials.
Topics: Albumins; Anti-Bacterial Agents; Cell Membrane; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Structure-Activity Relationship | 2022 |
Design and evaluation of poly-nitrogenous adjuvants capable of potentiating antibiotics in Gram-negative bacteria.
Topics: | 2022 |
Serum concentrations of penicillin, doxycycline, and ciprofloxacin during prolonged therapy in rhesus monkeys.
Topics: Animals; Ciprofloxacin; Doxycycline; Drug Administration Schedule; Female; Macaca mulatta; Male; Penicillin G; Penicillin G Procaine; Time Factors | 1992 |
Comparative efficacy of cefoperazone, cefoperazone plus sulbactam, ciprofloxacin, clindamycin, metronidazole, and penicillin G against anaerobic bacteria in an animal model.
Topics: Animals; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; Cefoperazone; Ciprofloxacin; Clindamycin; Clostridium Infections; Clostridium perfringens; Drug Therapy, Combination; Female; Metronidazole; Microbial Sensitivity Tests; Penicillin G; Peptostreptococcus; Prevotella melaninogenica; Rabbits; Sulbactam | 1990 |
[Multi-step increase in resistance of Neisseria gonorrhoeae isolates after repeated in-vitro subinhibitory concentrations of second-generation quinolones].
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; In Vitro Techniques; Neisseria gonorrhoeae; Penicillin G; Rifampin | 1989 |
Comparison of in vivo and in vitro activities of antibiotics with different modes of action against a tolerant and a non-tolerant Staphylococcus aureus strain.
Topics: Agranulocytosis; Animals; Ciprofloxacin; Drug Resistance, Microbial; Erythromycin; Mice; Penicillin G; Penicillin Resistance; Rifampin; Staphylococcal Infections; Staphylococcus aureus | 1989 |
Chemotherapy of experimental (murine) Clostridium perfringens type A gas gangrene.
Topics: Animals; Ciprofloxacin; Clindamycin; Clostridium perfringens; Disease Models, Animal; Gas Gangrene; Imipenem; Mice; Microbial Sensitivity Tests; Penicillin G; Rifampin | 1988 |
In vivo and in vitro activity of ciprofloxacin plus azlocillin against 12 streptococcal isolates in a neutropenic site model.
Topics: Amikacin; Animals; Azlocillin; Ciprofloxacin; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Enterococcus faecalis; Female; Gentamicins; Kinetics; Neutropenia; Penicillin G; Rabbits; Streptococcal Infections; Streptococcus; Streptococcus pneumoniae | 1987 |
[Comparative bactericidal kinetics of ciprofloxacin, ofloxacin and pefloxacin alone and in combination against strains of group D Streptococcus].
Topics: Amoxicillin; Anti-Bacterial Agents; Ciprofloxacin; Drug Synergism; Enterococcus faecalis; Fosfomycin; Microbial Sensitivity Tests; Netilmicin; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Penicillin G; Vancomycin | 1988 |
Recrudescence and relapse of meningococcal meningitis and septicaemia.
Topics: Administration, Oral; Anti-Bacterial Agents; Bacteremia; Child, Preschool; Chloramphenicol; Ciprofloxacin; Female; Follow-Up Studies; Humans; Hydrocortisone; Infant; Injections, Intravenous; Male; Meningitis, Meningococcal; Methylprednisolone; Penicillin G; Penicillin V; Recurrence; Rifampin; Time Factors | 1995 |
Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodology.
Topics: Anti-Infective Agents; Ciprofloxacin; Erythromycin; Fluoroquinolones; Kinetics; Microbial Sensitivity Tests; Penicillin G; Quinolones; Streptococcus pneumoniae; Time Factors; Vancomycin; Virginiamycin | 1994 |
Stevens-Johnson syndrome presumably induced by ciprofloxacin.
Topics: Adult; Ciprofloxacin; Humans; Male; Penicillin G; Stevens-Johnson Syndrome; Streptococcal Infections; Streptococcus pyogenes; Tonsillitis | 1994 |
Evaluation of the E test for antimicrobial susceptibility testing of Porphyromonas gingivalis.
Topics: Ampicillin; Anti-Bacterial Agents; Cefaclor; Cefuroxime; Ciprofloxacin; Clindamycin; Colony Count, Microbial; Doxycycline; Erythromycin; Evaluation Studies as Topic; Metronidazole; Microbial Sensitivity Tests; Penicillin G; Porphyromonas gingivalis; Tetracyclines | 1994 |
Antibiotic release from impregnated pellets and beads.
Topics: Amoxicillin; Anti-Bacterial Agents; Biological Assay; Calcium Sulfate; Ciprofloxacin; Drug Carriers; Floxacillin; Gentamicins; Imipenem; In Vitro Techniques; Methylmethacrylates; Penicillin G | 1994 |
Campylobacter rectus in human periodontitis.
Topics: Adolescent; Adult; Age Distribution; Aged; Campylobacter; Chi-Square Distribution; Ciprofloxacin; Cross-Sectional Studies; Female; Humans; Longitudinal Studies; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Odds Ratio; Penicillin G; Periodontal Pocket; Periodontitis; Sensitivity and Specificity; Sex Distribution; Subgingival Curettage; Tetracycline; Time Factors | 1993 |
In vitro antimicrobial susceptibility of different serotypes of Actinobacillus actinomycetemcomitans.
Topics: Aggregatibacter actinomycetemcomitans; Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Cefaclor; Cefuroxime; Ciprofloxacin; Doxycycline; Drug Resistance, Microbial; Erythromycin; Metronidazole; Penicillin G; Penicillin Resistance; Serotyping; Tetracycline; Tetracycline Resistance; Trimethoprim, Sulfamethoxazole Drug Combination | 1993 |
Beta-hemolytic streptococci in advanced periodontitis.
Topics: Adolescent; Adult; Age Factors; Aged; Ciprofloxacin; Colony Count, Microbial; Cross-Sectional Studies; Female; Hemolysis; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Penicillin G; Periodontitis; Prevalence; Serotyping; Streptococcus; Tetracycline | 1993 |
Evaluation of penicillin G in the prevention of streptococcal septicaemia in patients with acute myeloid leukaemia undergoing cytotoxic chemotherapy.
Topics: Adult; Aged; Antineoplastic Agents; Bacteremia; Ciprofloxacin; Humans; Leukemia, Myeloid, Acute; Middle Aged; Penicillin G; Streptococcal Infections | 1993 |
Evaluation of the efficacy of ciprofloxacin against Streptococcus pneumoniae by using a mouse protection model.
Topics: Animals; Ciprofloxacin; Half-Life; Mice; Microbial Sensitivity Tests; Penicillin G; Pneumococcal Infections; Streptococcus pneumoniae | 1993 |
[In vitro evaluation of antibiotic diffusion from antibiotic impregnated xenografts].
Topics: Anti-Bacterial Agents; Ciprofloxacin; Diffusion; Drug Delivery Systems; Gentamicins; Humans; In Vitro Techniques; Osteitis; Penicillin G; Transplantation, Heterologous | 1996 |
Susceptibility testing of fastidious organisms.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Culture Media; Lactams; Meropenem; Microbial Sensitivity Tests; Neisseria; Neisseria gonorrhoeae; Neisseria meningitidis; Penicillin G; Spectinomycin; Thienamycins | 1997 |
[Standardization of the Neisseria meningitidis antibiogram. Detection of strains relatively resistant to penicillin].
Topics: Amoxicillin; Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Cefotaxime; Ceftriaxone; Cephalosporins; Chloramphenicol; Ciprofloxacin; Drug Resistance, Microbial; Microbial Sensitivity Tests; Neisseria meningitidis; Penicillin G; Penicillin Resistance; Penicillins; Rifampin; Spiramycin | 1998 |
Adsorption and release of antibiotics from morselized cancellous bone. In vitro studies of 8 antibiotics.
Topics: Adsorption; Anti-Bacterial Agents; Biological Assay; Bone Transplantation; Cephalosporins; Ciprofloxacin; Clindamycin; Colony Count, Microbial; Drug Carriers; Drug Evaluation, Preclinical; Drug Stability; Humans; Netilmicin; Penicillin G; Rifampin; Temperature; Time Factors; Transplantation, Homologous; Vancomycin | 1999 |
[In vitro activities of levofloxacin and other antibiotics against fresh clinical isolates].
Topics: Ampicillin; Anti-Infective Agents; Bacteria; Bacterial Infections; Cefaclor; Cefpodoxime; Ceftizoxime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Humans; Levofloxacin; Methicillin; Ofloxacin; Penicillin G; Penicillin Resistance; Penicillins | 1999 |
[The frequency of Streptococcus pneumoniae strains and sensitivity surveillance for several antibiotics in Gifu Prefecture].
Topics: Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cefdinir; Cefixime; Cefmenoxime; Cefpodoxime; Ceftizoxime; Cephalosporins; Ciprofloxacin; Clarithromycin; Clindamycin; Drug Resistance, Microbial; Fluoroquinolones; Humans; Imipenem; Japan; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Ofloxacin; Penicillin G; Penicillins; Streptococcus pneumoniae; Thienamycins | 2000 |
Microbiological and chemical detection of incurred penicillin G, oxytetracycline, enrofloxacin and ciprofloxacin residues in bovine and porcine tissues.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cattle; Ciprofloxacin; Drug Residues; Enrofloxacin; Fluoroquinolones; Humans; Kidney; Muscles; Oxytetracycline; Penicillin G; Quinolones; Swine | 2000 |
Antimicrobial susceptibility of Listeria monocytogenes isolated from meningoencephalitis in sheep.
Topics: Amoxicillin; Animal Feed; Animals; Anti-Bacterial Agents; Brain; Cephalosporins; Cephalothin; Chloramphenicol; Ciprofloxacin; Doxycycline; Drug Resistance, Microbial; Erythromycin; Gentamicins; Kanamycin; Listeria monocytogenes; Listeriosis; Meningoencephalitis; Microbial Sensitivity Tests; Penicillin G; Penicillins; Rifampin; Sheep; Sheep Diseases; Sulfisoxazole; Tetracycline; Trimethoprim; Vancomycin | 2001 |
[Borrelia burgdorferi Group: in-vitro antibiotic sensitivity].
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Borrelia burgdorferi Group; Cephalosporins; Ciprofloxacin; Erythromycin; In Vitro Techniques; Microbial Sensitivity Tests; Penicillin G; Penicillins; Tetracycline | 2002 |
[Drug interactions between nonsteroidal anti-inflammatory drug and pazufloxacin mesilate, a new quinolone antibacterial agent for intravenous use: convulsions in mice after intravenous or intracerebroventricular administration].
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; beta-Alanine; Biphenyl Compounds; Cefazolin; Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Convulsants; Drug Combinations; Drug Interactions; Enoxacin; Fleroxacin; Fluoroquinolones; Imipenem; Injections, Intravenous; Injections, Intraventricular; Male; Mice; Mice, Inbred ICR; Norfloxacin; Oxazines; Penicillin G; Quinolones; Seizures; Thienamycins | 2002 |
Antimicrobial susceptibilities of 40 isolates of Bacillus anthracis isolated in Turkey.
Topics: Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Ciprofloxacin; Doxycycline; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; In Vitro Techniques; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Penicillin G; Penicillins; Turkey | 2003 |
Antimicrobial susceptibility of Neisseria gonorrhoeae strains isolated in Guangzhou, China, 1996-2001.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Ciprofloxacin; Colony Count, Microbial; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillin G; Spectinomycin | 2003 |
[Isolation-frequency and antibiotic susceptibility of Streptococcus pneumoniae, Haemophilus influenzae, and Pseudomonas aeruginosa isolated in regional core hospitals in the Nagaoka district of Niigata Prefecture (changes for 3 years)].
Topics: Anti-Infective Agents; Carbapenems; Ciprofloxacin; Drug Resistance, Bacterial; Haemophilus influenzae; Hospitals, Urban; Humans; Japan; Levofloxacin; Ofloxacin; Penicillin G; Pseudomonas aeruginosa; Streptococcus pneumoniae; Time Factors | 2004 |
An unusually extensive case of cutaneous anthrax in a patient with type II diabetes mellitus.
Topics: Aged; Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Ciprofloxacin; Diabetes Mellitus, Type 2; Humans; Male; Penicillin G; Skin Diseases, Bacterial; Treatment Outcome; Turkey; Zoonoses | 2005 |
[Clinical cases in Medical Mycology. Case No. 28].
Topics: Abdominal Injuries; Agricultural Workers' Diseases; Anti-Bacterial Agents; Argentina; Ciprofloxacin; Drug Therapy, Combination; Endemic Diseases; Humans; Male; Middle Aged; Mycetoma; Nocardia; Nocardia Infections; Penicillin G; Syphilis; Trimethoprim, Sulfamethoxazole Drug Combination; Wound Infection | 2007 |
Efflux pump gene hefA of Helicobacter pylori plays an important role in multidrug resistance.
Topics: Animals; Anti-Bacterial Agents; ATP Binding Cassette Transporter, Subfamily B; Bacterial Proteins; Ciprofloxacin; Drug Resistance, Multiple; Erythromycin; Genes, Bacterial; Genes, MDR; Helicobacter pylori; Metronidazole; Mutation; Penicillin G; RNA, Messenger; Tetracycline | 2008 |
Neisseria gonorrhoeae antibiotic resistance in Paris, 2005 to 2007: implications for treatment guidelines.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae; Paris; Penicillin G; Practice Guidelines as Topic; Prospective Studies; Risk Factors; Sexual Behavior; Spectinomycin; Tetracycline; Time Factors; Young Adult | 2009 |
[Cerebral actinomycosis pseudotumor: a case report].
Topics: Actinomycosis; Adrenal Cortex Hormones; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ciprofloxacin; Combined Modality Therapy; Dental Caries; Drug Therapy, Combination; Dysarthria; Humans; Male; Metronidazole; Middle Aged; Occipital Lobe; Oral Hygiene; Paresis; Penicillin G; Periapical Abscess; Pseudotumor Cerebri; Seizures; Tomography, X-Ray Computed | 2011 |
Antimicrobial resistance and molecular typing of Neisseria gonorrhoeae isolates in Kyoto and Osaka, Japan, 2010 to 2012: intensified surveillance after identification of the first strain (H041) with high-level ceftriaxone resistance.
Topics: Anti-Bacterial Agents; Antigens, Bacterial; Azithromycin; beta-Lactam Resistance; Cefixime; Ceftriaxone; Ciprofloxacin; Epidemiological Monitoring; Female; Gonorrhea; Humans; Incidence; Japan; Male; Microbial Sensitivity Tests; Multilocus Sequence Typing; Neisseria gonorrhoeae; Penicillin G | 2013 |
Antibiotic resistance and capacity for biofilm formation of different bacteria isolated from endodontic infections associated with root-filled teeth.
Topics: Actinomyces; Actinomyces viscosus; Amoxicillin; Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Clindamycin; Dental Pulp Diseases; Doxycycline; Drug Resistance, Bacterial; Enterococcus faecalis; Fluoroquinolones; Fosfomycin; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Limosilactobacillus fermentum; Moxifloxacin; Penicillin G; Penicillin Resistance; Prevotella; Propionibacterium; Rifampin; Streptococcus mutans; Tetracycline Resistance; Tooth, Nonvital; Vancomycin Resistance | 2014 |
Unusual cause of fatal anthrax meningitis.
Topics: Anthrax; Anti-Bacterial Agents; Ciprofloxacin; Fatal Outcome; Female; Humans; Meningitis; Middle Aged; Penicillin G; Skin Diseases, Bacterial; Turkey | 2015 |
Time-kill curve analysis and pharmacodynamic modelling for in vitro evaluation of antimicrobials against Neisseria gonorrhoeae.
Topics: Anti-Bacterial Agents; Cefixime; Ceftriaxone; Cell Count; Cell Survival; Chloramphenicol; Ciprofloxacin; Gentamicins; Growth Charts; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Models, Theoretical; Neisseria gonorrhoeae; Penicillin G; Spectinomycin; Tetracycline; Time Factors | 2016 |
WGS to predict antibiotic MICs for Neisseria gonorrhoeae.
Topics: Anti-Bacterial Agents; Azithromycin; Canada; Cefixime; Ciprofloxacin; Drug Resistance, Bacterial; England; Genome, Bacterial; Gonorrhea; High-Throughput Nucleotide Sequencing; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillin G; Tetracycline; United States; Whole Genome Sequencing | 2017 |
Life-Threatening Atypical Case of Acute Generalized Exanthematous Pustulosis.
Topics: Acute Generalized Exanthematous Pustulosis; Adult; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Enterococcus faecium; Humans; Male; Penicillin G; Periodontitis; Staphylococcal Infections; Staphylococcus aureus; Sulbactam; Systemic Inflammatory Response Syndrome | 2017 |
Surveillance of antimicrobial resistance in Neisseria meningitidis strains isolated from invasive cases in Brazil from 2009 to 2016.
Topics: Adolescent; Ampicillin; Anti-Infective Agents; Brazil; Ceftriaxone; Child; Child, Preschool; Chloramphenicol; Ciprofloxacin; Drug Resistance, Bacterial; Epidemiological Monitoring; Female; Humans; Infant; Male; Meningococcal Infections; Microbial Sensitivity Tests; Neisseria meningitidis; Penicillin G; Rifampin | 2018 |
Performance characteristics of newer MIC gradient strip tests compared with the Etest for antimicrobial susceptibility testing of Neisseria gonorrhoeae.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Data Accuracy; Disk Diffusion Antimicrobial Tests; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillin G; Sensitivity and Specificity | 2018 |
Effects of Microplate Type and Broth Additives on Microdilution MIC Susceptibility Assays.
Topics: Aminoglycosides; Anti-Bacterial Agents; Calcium; Ciprofloxacin; Colistin; Culture Media; Depsipeptides; Escherichia coli; Factor Analysis, Statistical; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Penicillin G; Plastics; Polymyxin B; Polysorbates; Rifampin; Teicoplanin; Trimethoprim; Vancomycin | 2019 |
Antimicrobial Resistance of Neisseria Gonorrhoeae in a Newly Implemented Surveillance Program in Uganda: Surveillance Report.
Topics: Adult; Anti-Bacterial Agents; Cefixime; Ceftriaxone; Ciprofloxacin; Demography; Drug Resistance, Bacterial; Female; Gonorrhea; Humans; Male; Neisseria gonorrhoeae; Penicillin G; Population Surveillance; Sentinel Surveillance; Spectinomycin; Tetracycline; Uganda | 2020 |
Biofilm formation on endovascular aneurysm repair (EVAR) grafts-a proof of concept in vitro model.
Topics: Anti-Bacterial Agents; Aortic Aneurysm, Abdominal; Bacteria; Biofilms; Blood Vessel Prosthesis Implantation; Ciprofloxacin; Endovascular Aneurysm Repair; Endovascular Procedures; Humans; Penicillin G; Staphylococcus aureus; Tobramycin | 2023 |
Antimicrobial Resistance and Molecular Typing of Neisseria gonorrhoeae Isolates From the Eastern Cape Province in South Africa.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Molecular Typing; Mycobacterium tuberculosis; Neisseria gonorrhoeae; Penicillin G; South Africa; Tetracycline | 2023 |